DK3328992T3 - Fremgangsmåder til fremstilling af decellulariserede vævs-scaffolds - Google Patents
Fremgangsmåder til fremstilling af decellulariserede vævs-scaffolds Download PDFInfo
- Publication number
- DK3328992T3 DK3328992T3 DK16750213.7T DK16750213T DK3328992T3 DK 3328992 T3 DK3328992 T3 DK 3328992T3 DK 16750213 T DK16750213 T DK 16750213T DK 3328992 T3 DK3328992 T3 DK 3328992T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- decellularized tissue
- tissue scaffolds
- making
- making decellularized
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502707—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the manufacture of the container or its components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/33—Disintegrators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M45/00—Means for pre-treatment of biological substances
- C12M45/02—Means for pre-treatment of biological substances by mechanical forces; Stirring; Trituration; Comminuting
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
- C12N5/0671—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0679—Cells of the gastro-intestinal tract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0864—Configuration of multiple channels and/or chambers in a single devices comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0867—Multiple inlets and one sample wells, e.g. mixing, dilution
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0487—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2527/00—Culture process characterised by the use of mechanical forces, e.g. strain, vibration
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Botany (AREA)
- Sustainable Development (AREA)
- Analytical Chemistry (AREA)
- Clinical Laboratory Science (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Mechanical Engineering (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1513461.2A GB201513461D0 (en) | 2015-07-30 | 2015-07-30 | Methods and devices for the production of decellularised tissue scaffolds |
PCT/GB2016/052349 WO2017017474A1 (en) | 2015-07-30 | 2016-07-29 | Methods and devices for the production of decellularised tissue scaffolds |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3328992T3 true DK3328992T3 (da) | 2020-12-21 |
Family
ID=54062918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16750213.7T DK3328992T3 (da) | 2015-07-30 | 2016-07-29 | Fremgangsmåder til fremstilling af decellulariserede vævs-scaffolds |
Country Status (8)
Country | Link |
---|---|
US (1) | US10792395B2 (da) |
EP (1) | EP3328992B1 (da) |
JP (1) | JP6969069B2 (da) |
CN (1) | CN108026509B (da) |
DK (1) | DK3328992T3 (da) |
ES (1) | ES2843977T3 (da) |
GB (1) | GB201513461D0 (da) |
WO (1) | WO2017017474A1 (da) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2016001247A (es) | 2013-07-30 | 2016-08-17 | Musculoskeletal Transplant Foundation | Matrices derivadas de tejido suave acelular y metodos para preparar las mismas. |
US10912864B2 (en) | 2015-07-24 | 2021-02-09 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
CN107007885A (zh) * | 2017-03-06 | 2017-08-04 | 同坤源(天津)医药科技有限公司 | 胎盘细胞外基质的制备方法 |
CN107213513B (zh) * | 2017-05-31 | 2020-09-18 | 陕西瑞盛生物科技有限公司 | 一种生物材料的脱细胞装置及脱细胞方法 |
CN107224612B (zh) * | 2017-05-31 | 2020-09-18 | 陕西瑞盛生物科技有限公司 | 一种自动化脱细胞系统及脱细胞方法 |
CN107158464B (zh) * | 2017-05-31 | 2020-10-30 | 陕西瑞盛生物科技有限公司 | 一种自动补液式脱细胞系统 |
CN106963985B (zh) * | 2017-05-31 | 2020-09-18 | 陕西瑞盛生物科技有限公司 | 一种脱细胞网箱及脱细胞装置 |
CN107281551A (zh) * | 2017-07-11 | 2017-10-24 | 温旭东 | 冰冻法制备肝脏生物支架的方法 |
CN107988158B (zh) * | 2017-11-27 | 2020-11-13 | 大连理工大学 | 一种三维肿瘤模型脱细胞多孔支架、构建方法及其应用 |
US11602548B1 (en) | 2018-02-26 | 2023-03-14 | Convatec, Inc | Fibrous birth tissue composition and method of use |
US11026980B1 (en) | 2018-02-26 | 2021-06-08 | Triad Life Sciences, Inc. | Flowable birth tissue composition and related methods |
CN108424878A (zh) * | 2018-03-26 | 2018-08-21 | 南通大学附属医院 | 乳腺癌及乳腺组织ecm及其制备方法和乳腺癌3d体外培养模型的构建方法 |
CN110947024B (zh) * | 2018-09-26 | 2024-04-02 | 成都清科生物科技有限公司 | 羊膜制备系统及羊膜生产系统 |
CN109536436A (zh) * | 2018-10-17 | 2019-03-29 | 重庆医科大学附属儿童医院 | 一种人源性肝硬化ecm生物支架的制备方法 |
CN109602954A (zh) * | 2018-12-17 | 2019-04-12 | 浙江华臻医疗器械有限公司 | 一种脱细胞神经基质及其制备方法 |
CN109621010A (zh) * | 2018-12-17 | 2019-04-16 | 浙江华臻医疗器械有限公司 | 一种脱细胞软骨基质及其制备方法 |
CN109679891B (zh) * | 2018-12-18 | 2022-10-18 | 重庆医科大学附属儿童医院 | 一种新型人肝脏生物支架立体培养系统下乙肝病毒感染模型的建立 |
KR102411248B1 (ko) * | 2019-06-21 | 2022-06-21 | 주식회사 에스앤지바이오텍 | 무세포화 처리방법 |
CN110433341A (zh) * | 2019-08-29 | 2019-11-12 | 上海白衣缘生物工程有限公司 | 一种组织修复材料及其制备方法 |
CN110404113A (zh) * | 2019-08-29 | 2019-11-05 | 上海白衣缘生物工程有限公司 | 一种制备无细胞医用植入材料的方法 |
CN110448730A (zh) * | 2019-08-29 | 2019-11-15 | 上海白衣缘生物工程有限公司 | 一种用于鼓膜修复的生物补片及其制备方法 |
CN110559485B (zh) * | 2019-09-25 | 2021-02-02 | 北京大清生物技术股份有限公司 | 一种生物组织基质材料及其制备方法与应用 |
BR112022016428A2 (pt) * | 2020-02-21 | 2022-11-16 | Convatec Triad Life Sciences Llc | Uso de matriz extracelular placentária porcina descelularizada, estruturas porcinas e seus métodos de preparação |
CN111359016B (zh) * | 2020-03-13 | 2021-12-07 | 青岛海洋生物医药研究院 | 一种低抗原性鱼皮组织及其处理方法 |
US20210322154A1 (en) * | 2020-04-15 | 2021-10-21 | Vitae LLC | Method of Processing Collagen-based Tissue for Bioprosthetic Devices |
WO2021242822A1 (en) * | 2020-05-26 | 2021-12-02 | Triad Life Sciences, Inc. | Modified porcine scaffolds and methods of preparation |
GB202013270D0 (en) | 2020-08-25 | 2020-10-07 | Engitix Ltd | Anti-fibrotic combination |
WO2022080876A1 (ko) * | 2020-10-15 | 2022-04-21 | 주식회사 엘앤씨바이오 | 진피 조직 유래 세포외기질을 이용한 유방재건용 지지체 및 그 제조 방법 |
CN112336919A (zh) * | 2020-11-10 | 2021-02-09 | 广州华腾生物医药科技有限公司 | 用于组织脱细胞的复合溶液、其制备方法以及组织脱细胞的方法 |
CN113262328B (zh) * | 2021-03-19 | 2023-07-14 | 宁波市第一医院 | 一种全自动、标准化生物组织脱细胞装置 |
CN114209886B (zh) * | 2021-11-09 | 2022-12-02 | 江苏臻亿医疗科技有限公司 | 一种生物组织材料及其制备方法 |
GB2616667A (en) * | 2022-03-18 | 2023-09-20 | Entia Ltd | A composition for coating a cuvette and a method of making a composition for coating a cuvette |
CN115453021B (zh) * | 2022-08-15 | 2023-11-14 | 首都医科大学附属北京友谊医院 | 一种sds脱细胞溶液及其在脱细胞处理或细胞外基质不可溶组分鉴定中的应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050249816A1 (en) * | 1999-12-29 | 2005-11-10 | Wake Forest University Health Services | Tissue engineered liver constructs |
US6376244B1 (en) * | 1999-12-29 | 2002-04-23 | Children's Medical Center Corporation | Methods and compositions for organ decellularization |
CN101954124B (zh) * | 2010-08-31 | 2014-06-04 | 中国人民解放军第二军医大学 | 含基底膜的组织工程皮肤的构建方法 |
CN103007350A (zh) * | 2012-12-14 | 2013-04-03 | 中国人民解放军第三军医大学第二附属医院 | 改性大鼠脱细胞脊髓支架材料及制备方法 |
CN103751845B (zh) * | 2014-01-30 | 2015-05-13 | 中国人民解放军海军总医院 | 一种用于移植修复周围神经缺损的组织工程生物材料 |
CN104399125B (zh) * | 2014-12-01 | 2016-03-16 | 中国人民解放军第三军医大学第三附属医院 | 表皮干细胞向汗腺样上皮细胞分化的方法 |
CN104888276B (zh) * | 2015-05-05 | 2018-01-02 | 北京帝康医药投资管理有限公司 | 一种心肌组织工程产品及其制备方法和用途 |
-
2015
- 2015-07-30 GB GBGB1513461.2A patent/GB201513461D0/en not_active Ceased
-
2016
- 2016-07-29 JP JP2018504719A patent/JP6969069B2/ja active Active
- 2016-07-29 WO PCT/GB2016/052349 patent/WO2017017474A1/en active Application Filing
- 2016-07-29 EP EP16750213.7A patent/EP3328992B1/en active Active
- 2016-07-29 CN CN201680050591.0A patent/CN108026509B/zh active Active
- 2016-07-29 US US15/748,390 patent/US10792395B2/en active Active
- 2016-07-29 DK DK16750213.7T patent/DK3328992T3/da active
- 2016-07-29 ES ES16750213T patent/ES2843977T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
GB201513461D0 (en) | 2015-09-16 |
JP6969069B2 (ja) | 2021-11-24 |
CN108026509A (zh) | 2018-05-11 |
CN108026509B (zh) | 2021-07-06 |
US20180214609A1 (en) | 2018-08-02 |
US10792395B2 (en) | 2020-10-06 |
JP2018522561A (ja) | 2018-08-16 |
EP3328992B1 (en) | 2020-11-04 |
ES2843977T3 (es) | 2021-07-21 |
WO2017017474A1 (en) | 2017-02-02 |
EP3328992A1 (en) | 2018-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3328992T3 (da) | Fremgangsmåder til fremstilling af decellulariserede vævs-scaffolds | |
DK3473783T3 (da) | Fremgangsmåde til fremstilling af gulvplader | |
DK3286311T3 (da) | Fremgangsmåde til behandling af maligniteter | |
DK3294700T3 (da) | Fremgangsmåde til fremstilling af limonen-4-ol | |
DK3192902T3 (da) | Fremgangsmåde til fremstilling af graphenholdige viscosefibre | |
DK3247371T3 (da) | Fremgangsmåder til oprensning af cannabinoider, sammensætninger og kits dertil | |
DK3096741T3 (da) | Fremgangsmåde til fremstillingen af hybridosomer | |
DK3072835T3 (da) | Fremgangsmåde til fremføring | |
DK3174858T3 (da) | Fremgangsmåde til fremstilling af pyrazoler | |
DK3325443T3 (da) | Fremgangsmåde til fremstilling af pridopidin | |
DK3317400T3 (da) | Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter | |
DK3303618T3 (da) | Fremgangsmåder til prognose af prostatacancer | |
DK3122444T3 (da) | Fremgangsmåde til fremstilling af membraner | |
DK3126373T3 (da) | Fremgangsmåde til fremstilling af amg 416 | |
DK3152176T3 (da) | Fremgangsmåde til fremstillingen af en cementforbindelse | |
DK3302063T3 (da) | Fremgangsmåde til stimulering af frø | |
DK3233813T3 (da) | Fremgangsmåder til fremstilling af oxathiazin-lignende forbindelser | |
DK3280408T3 (da) | Fremgangsmåde til fremstilling af dicycloplatin | |
DK3529233T3 (da) | Fremgangsmåde til fremstilling af 3-alkylsulfanyl-2-chlor-n-(1-alkyl-1h-tetrazol-5-yl)-4-trifluoromethyl-benzamider | |
DK3274143T3 (da) | Fremgangsmåde til fremstilling af lignocellulosematerialer | |
DK3304037T3 (da) | Fremgangsmåde til opsamling af cellekolonier | |
DK2910535T3 (da) | Sammensætning til anvendelse af ekspanderet perlit | |
DK3347307T3 (da) | Fremgangsmåde til ekstraktionen af silikat | |
DK3265439T3 (da) | Fremgangsmåde til fremstilling af 3-chlor-2-vinylphenylsulfonater | |
DK3507282T3 (da) | Fremgangsmåde til fremstilling af indolcarboxamidforbindelser |